Etorip-MR Tablet is a combination medication containing Etodolac 200mg and Thiocolchicoside 4mg, designed to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Etodolac, a nonsteroidal anti-inflammatory drug (NSAID), works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, swelling, and inflammation. Thiocolchicoside, a muscle relaxant, acts on the central nervous system to relieve muscle spasms and stiffness, improving mobility and comfort. This synergistic formulation is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis, acute musculoskeletal injuries, and lower back pain. Etorip-MR Tablet helps in alleviating pain, reducing inflammation, and relaxing tense muscles, facilitating faster recovery and enhanced quality of life. It should be taken as directed by a healthcare professional, typically after meals to minimize gastrointestinal discomfort. Patients with a history of hypersensitivity to NSAIDs, peptic ulcers, or severe liver or kidney impairment should use this medication cautiously. Common side effects may include gastrointestinal upset, dizziness, or mild allergic reactions. Consultation with a physician is essential before starting Etorip-MR Tablet to ensure safe and appropriate use tailored to individual health needs.